The present invention is a sealable microampule for storage of environment sensitive material which is autosampler compatible and provides a space, small enough to make low volumes of liquid available for auto-injector needle. The microampule fits inside an autosampler vial and breaks open at a certain height to allow stable accommodation inside the autosampler vial. The microampule has a longer length which provides space to apply the force to snap break the seal at the opening level of the autosampler vial.

An illustrated view of an exemplary emergency kit for use in an emergency medical condition and a method for automating the ordering of the emergency kits for dentist is presented. The emergency kit is useful for providing short-term medical relief in an emergency while waiting for ambulance or other emergency medical personnel to arrive at the scene. The emergency kit provides a useful medical syringe for use by a dentist in a mouth of a patient experiencing an emergency medical condition.

The disclosure relates to a syringe, comprising a syringe body with a nozzle and a threaded connection. The syringe body comprises a side wall and a front wall, wherein the syringe body comprises a cycloolefin as a first material, at least in portions. The first material forms an internal wall of the syringe body. The threaded connection comprises, at least in portions, as a second material a material other than the cycloolefin, wherein the first and the second material are integrally bonded to one another. The second material extends in the region of the front wall at least in portions over the first material, so that the front wall comprises, at least in portions, a two-layer region. The first and the second material in the two-layer region have a mutually engaging structure.

To provide a method for manufacturing a medical glass container prevented from breakage and deformation and a fire blasting device. A method for manufacturing a medical glass container includes a processing process of placing a glass container 10 on the outer peripheral surface of each of a first roller 61 and a second roller 62, which are disposed side by side in such a manner that the axis lines are parallel to each other, so that the axis line of the glass container 10 is parallel to the axis lines of the first roller 61 and the second roller 62 and the entire outer peripheral surface in an inner surface 15 of the glass container 10 corresponding to a region deteriorated by processing is made to abut on the outer peripheral surface of each of the first roller 61 and the second roller 62, and then applying a flame ejected from a point burner 30 to the region deteriorated by processing in the inner surface 15 of the glass container 10 while rotating the glass container 10 by rotating the first roller 61 and the second roller 62 around the axis lines.

A resin hollow needle includes a distal end section including a puncture end portion, a large-diameter section having a diameter greater than that of the distal end section, a tapered section that is located between the large-diameter section and the distal end section, and a hub section. The distal end section includes a hole that is provided on a proximal end side in comparison to a distal end and on a distal end side of the tapered section, and communicates with the inside and the outside of a hollow needle, and a tapered puncture end portion. The distal end section has a total length of 7 to 14 mm and a maximum outer diameter of 1.5 to 3.0 mm. The tapered section has a length of 0.3 to 4.7 mm and a taper angle of 10° to 50°. The large-diameter section has a length of 4 mm or greater, and a distal end outer diameter that is greater than the maximum outer diameter of the distal end section by 0.6 to 3.0 mm.

A resin hollow needle includes a distal end section including a puncture end portion, a large-diameter section having a diameter greater than that of the distal end section, a tapered section that is located between the large-diameter section and the distal end section, and a hub section. The distal end section includes a hole that is provided on a proximal end side in comparison to a distal end and on a distal end side of the tapered section, and communicates with the inside and the outside of a hollow needle, and a tapered puncture end portion. The distal end section has a total length of 7 to 14 mm and a maximum outer diameter of 1.5 to 3.0 mm. The tapered section has a length of 0.3 to 4.7 mm and a taper angle of 10° to 50°. The large-diameter section has a length of 4 mm or greater, and a distal end outer diameter that is greater than the maximum outer diameter of the distal end section by 0.6 to 3.0 mm.

The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, RITUXAN (rituximab), AVASTIN (Bevacizumab), LUCENTIS (Ranibizumab) or HERCEPTIN (trastuzumab).

The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, HUMALOG (insulin lispro), HUMALOG MIX 75-25 (insulin lispro), HUMALOG MIX 50-50 (insulin lispro), HUMILIN 70-30 (insulin), HUMILIN N (insulin), HUMULIN R (insulin) or GEMZAR (gemcitabine).

Compositions are provided for the liquid oral administration of topiramate and its salts. The invention further provides methods for treating diseases and disorders using the compositions.

Compositions are provided for the liquid oral administration of topiramate and its salts. The invention further provides methods for treating diseases and disorders using the compositions.